AbbVie is a highly focused research-driven biopharmaceutical company. They partner in order to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people’s lives. Their partners share a commitment to solving the world’s greatest health needs. That’s why AbbVie collaborates with peers, biotech companies, universities, clinical experts and advocacy groups. By working together, they combine the best efforts, thinking and resources to find better solutions for patients.
On May 14th, the AbbVie team came to Heidelberg to hold a day of exchange with biotech, academia and consortia that may have innovative products or platforms in the following interest areas: Immunology – Oncology – Neuroscience – Academia – Platforms & Technologies.